Idea Visor is an intellectual property research and consulting firm that helps Fortune 500 technology-driven companies navigate the patent landscape and identify "white space" opportunities for innovation including "visionary" opportunities that can't be found through traditional market research.
Idea Visor offers a wide range of patent research and consulting services with a focus on identifying "white space" opportunities for innovation in the medical technology space.
We turn patent data into business insights that provide immediate value and impact to your business, marketing and technical team. We specialize in transforming hundreds or thousands of legal and technical patents and documents into clearly understandable and actionable business insights. Based upon our experience across a wide range of businesses and technologies, it is not an understatement for us to say:
"You will understand more about your competitors than they understand about themselves."
Our services are designed to help you extract the business value you need to reach your long term business goals. We can help you:
- Identify new opportunities for innovation
- Design around existing patents
- Assess the competitive advantages of your current strategy
- Identifying potential licensees for your IP
- Identify competitive threats
- Assess your freedom to operate
- Formulate an effective IP strategy
- Provide world-class idea management and portfolio management services
CHRIS FRANK, J.D.
Founder & President
Chris Frank founded Idea Visor, LLC in 2012 based upon the premise that, in the hands of the right professionals, the patent landscape offers a deep level of market, technical and business insights that can't be uncovered using traditional competitive research and intelligence methods. His experience includes a portfolio manager role in the neuromodulation space at Medtronic, Inc., with a focus on technologies for the treatment of Parkinson's disease, chronic pain and other neurodegenerative disorders. He also founded the Master of Science in Patent Law Program at the University of Minnesota where he developed and taught the Capstone: Innovation course, with a focus on tying business commercialization objectives to IP strategy. He has worked with clients ranging from start-up medical technology companies in the gene therapy space to Fortune 500 corporations in the medical products space. Chris Frank holds a B.S. in Chemical Engineering from the University of Wisconsin - Madison and a J.D. from William Mitchell College of Law.
S. B., MSPL & MBA
Science & Technology Innovation Advisor
S. B. is a Science and Technology Innovation Advisor at Idea Visor, LLC, specialising in outlining and executing patent strategies for small to mid-sized startups. She works with companies to provide an in-depth understanding of the technology and company vision and develops a strategy that achieves quality protection for the technology and meets budget goals, including evaluation of commercial potential and patentability, and performing market and competitive research. Her experience includes IP research and consulting services for companies in the Vagal Nerve Stimulation (VNS) space, the diabetes auto-injector space and in the biosimilars research and genetics categories. She holds Biotechnology degree from North Dakota State University (NDSU), Intellectual Property Law from the University of Minnesota and pursued her MBA in International Business.
WHAT OUR CLIENTS SAY
ASHISH KUMAR SRIVASTAV
Team Lead, IDS Infotech
“As a young, motivated and highly enthusiastic professional, S. B. is a true specialist in IP Law. I had the privilege of working with her while preparing interim & final patent reports to keep track of incoming and outgoing inventions with some fairly complex requirements. I greatly appreciate her high quality legal expertise ensuring the protection of IP portfolio in the many diverse areas. Her interest in knowing our business goals absolutely results in better outcomes for us. S. B.’s candor allows me personally to understand & make decisions quickly that I feel are in our best interest.”